maximum of 40mg consider with the Tachycardia patient/parent/carer Palpitations interruption of treatment Side effects Symptom control 2.0 NON-STIMULANT DRUG TREATMENT 2.1 Atomoxetine [AMBER] >6 yrs - GI Symptoms 6 monthly height & risk of hypertensive MAOI’s >70 kg, 40 mg daily for 7 days weight crisis Anorexia increase according to response. Perform comprehensive Dry mouth Usual maintenance dose 80 mg Increased risk of ventricular medical history including: Palpitation, tachycardia daily; max. 100 mg daily arrhythmias with concomitant Increased blood pressure, postural <70 kg, 500 micrograms/kg daily medications, Amiodarone hypotension for 7 days then increased family history Antidepressants, Tricyclics Restlessness, dizziness, headache according to response to usual past and present Antipsychotics Urinary retention, enuresis maintenance dose 1.2 mg/kg daily medical Disopyramide Sexual dysfunction, menstrual <6 years unlicensed disorders or disturbance Diuretics (hypokalaemia) symptoms Mefloquine Mydriasis, conjunctivitis Baseline evaluation of Dermatitis, sweating, weight changes Methadone cardiovascular status, Less commonly suicidal ideation Moxifloxacin including blood pressure Very rarely hepatic disorders. Procainamide (BP) and pulse, results to Sotalol be measured and recorded on centile chart or similar. The GP must be notified in writing of these results Establish and confirm
maximum of 40mg Tachycardia Palpitations consider with the patient/parent/carer interruption of treatment Side effects Symptom control 2.0 NON-STIMULANT DRUG TREATMENT 2.1 Atomoxetine [AMBER] >6 yrs - >70 kg, 40 mg daily for 7 days increase according to response. Usual maintenance dose 80 mg daily; max. 100 mg daily <70 kg, 500 micrograms/kg daily for 7 days then increased according to response to usual maintenance dose 1.2 mg/kg daily <6 years unlicensed GI Symptoms Anorexia Dry mouth Palpitation, tachycardia Increased blood pressure, postural hypotension Restlessness, dizziness, headache Urinary retention, enuresis Sexual dysfunction, menstrual disturbance Mydriasis, conjunctivitis Dermatitis, sweating, weight changes Less commonly suicidal ideation Very rarely hepatic disorders. 6 monthly height & weight Perform comprehensive medical history including: concomitant medications, family history past and present medical disorders or symptoms Baseline evaluation of cardiovascular status, including blood pressure (BP) and pulse, results to be measured and recorded on centile chart or similar. The GP must be notified in writing of these results Establish and confirm MAOI’s risk of hypertensive crisis Increased risk of ventricular arrhythmias with Amiodarone Antidepressants, Tricyclics Antipsychotics Disopyramide Diuretics (hypokalaemia) Mefloquine Methadone Moxifloxacin Procainamide Sotalol
ADHD%20Protocol.docx